Haleon plc (NYSE:HLN) Sees Large Increase in Short Interest

Haleon plc (NYSE:HLN - Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 12,420,000 shares, an increase of 5.8% from the November 15th total of 11,740,000 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily volume of 6,260,000 shares, the short-interest ratio is presently 2.0 days.

Haleon Stock Performance

Haleon stock traded down $0.04 during trading hours on Monday, reaching $9.72. 8,417,492 shares of the stock were exchanged, compared to its average volume of 5,418,738. Haleon has a 52-week low of $7.89 and a 52-week high of $10.80. The firm's 50 day moving average is $9.75 and its 200 day moving average is $9.53. The stock has a market cap of $44.00 billion, a P/E ratio of 28.71, a P/E/G ratio of 2.95 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Institutional Trading of Haleon

Institutional investors and hedge funds have recently modified their holdings of the business. AE Wealth Management LLC increased its holdings in Haleon by 6.1% in the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company's stock valued at $159,000 after purchasing an additional 1,098 shares in the last quarter. Lake Street Advisors Group LLC boosted its stake in shares of Haleon by 5.4% in the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company's stock valued at $237,000 after purchasing an additional 1,143 shares during the period. Endowment Wealth Management Inc. grew its holdings in Haleon by 9.9% during the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock valued at $106,000 after purchasing an additional 1,161 shares in the last quarter. Synovus Financial Corp increased its stake in Haleon by 0.8% during the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company's stock worth $1,575,000 after buying an additional 1,216 shares during the period. Finally, Hexagon Capital Partners LLC lifted its holdings in Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company's stock worth $84,000 after buying an additional 1,238 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on HLN. Morgan Stanley raised their target price on Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a report on Friday, September 20th. UBS Group upgraded shares of Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.